Jennifer Schranz - Net Worth and Insider Trading
Jennifer Schranz Net Worth
The estimated net worth of Jennifer Schranz is at least $0 dollars as of 2024-11-13. Jennifer Schranz is the Chief Medical Officer of Nabriva Therapeutics PLC and owns about 22 shares of Nabriva Therapeutics PLC (NBRVF) stock worth over $0. Details can be seen in Jennifer Schranz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jennifer Schranz has not made any transactions after 2018-06-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jennifer Schranz
Jennifer Schranz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jennifer Schranz owns 1 companies in total, including Nabriva Therapeutics PLC (NBRVF) .
Click here to see the complete history of Jennifer Schranz’s form 4 insider trades.
Insider Ownership Summary of Jennifer Schranz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NBRVF | Nabriva Therapeutics PLC | 2018-06-22 | Chief Medical Officer |
Jennifer Schranz Latest Holdings Summary
Jennifer Schranz currently owns a total of 1 stock. Jennifer Schranz owns 22 shares of Nabriva Therapeutics PLC (NBRVF) as of June 22, 2018, with a value of $0.
Latest Holdings of Jennifer Schranz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBRVF | Nabriva Therapeutics PLC | 2018-06-22 | 22 | 0.00 | 0 |
Holding Weightings of Jennifer Schranz
Jennifer Schranz Form 4 Trading Tracker
According to the SEC Form 4 filings, Jennifer Schranz has made a total of 0 transactions in Nabriva Therapeutics PLC (NBRVF) over the past 5 years. The most-recent trade in Nabriva Therapeutics PLC is the acquisition of 22 shares on June 22, 2018, which cost Jennifer Schranz around $20,515.
Insider Trading History of Jennifer Schranz
- 1
Jennifer Schranz Trading Performance
GuruFocus tracks the stock performance after each of Jennifer Schranz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jennifer Schranz is -33.77%. GuruFocus also compares Jennifer Schranz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jennifer Schranz within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jennifer Schranz's insider trading performs compared to the benchmark.
Performance of Jennifer Schranz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.42 | | | | | |
| Relative Return to S&P 500(%) | -11.12 | | | | | |
Jennifer Schranz Ownership Network
Ownership Network List of Jennifer Schranz
Ownership Network Relation of Jennifer Schranz
Jennifer Schranz Owned Company Details
What does Nabriva Therapeutics PLC do?
Who are the key executives at Nabriva Therapeutics PLC?
Jennifer Schranz is the Chief Medical Officer of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .
Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nabriva Therapeutics PLC Insider Transactions
Jennifer Schranz Mailing Address
Above is the net worth, insider trading, and ownership report for Jennifer Schranz. You might contact Jennifer Schranz via mailing address: 1000 Continental Drive, Suite 600, King Of Prussia Pa 19406.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
